Scientific Journals

	original article	Journal	Date	Title
1	[GO]	The Medical Letter on Drugs and Therapeutics	2025―Oct―09	COVID-19 Update: 2025-2026 Vaccine Formulations and Recommendations
2	[GO]	The Medical Letter on Drugs and Therapeutics	2025―Aug―26	COVID-19 Update: Full Approval for Novavax COVID-19 Vaccine
3	[GO]	The Medical Letter on Drugs and Therapeutics	2025―Aug―26	COVID-19 Update: mRNA COVID-19 Vaccines and Myocarditis
4	[GO]	The Medical Letter on Drugs and Therapeutics	2025―Aug―26	COVID-19 Update: mNEXSPIKE - A New Moderna mRNA Vaccine for COVID-19
5	[GO]	The Medical Letter on Drugs and Therapeutics	2024―Oct―10	COVID-19 Update: Novavax Vaccine for 2024-2025
6	[GO]	The Medical Letter on Drugs and Therapeutics	2024―Oct―01	Addendum: Effectiveness of mRNA COVID-19 Vaccines
7	[GO]	The Medical Letter on Drugs and Therapeutics	2024―Sep―19	COVID-19 Update: New Pfizer and Moderna Vaccine Formulations for 2024-2025
8	[GO]	The Medical Letter on Drugs and Therapeutics	2024―May―15	COVID-19 Update: An EUA for Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis
9	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Dec―11	Vaccination Recommendations for Updated 2023-2024 COVID-19 Vaccines
10	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Nov―21	COVID-19 Update: New Novavax Vaccine Formulation for 2023-2024
11	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Oct―03	COVID-19 Update: New Pfizer and Moderna Vaccine Formulations for 2023-2024
12	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Jul―26	Dosing Recommendations for Novavax and Johnson and Johnson COVID-19 Vaccines
13	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Jul―26	Vaccination Recommendations for Bivalent mRNA COVID-19 Vaccines
14	[GO]	The Medical Letter on Drugs and Therapeutics	2023―May―11	COVID-19 Update: Metformin to Prevent Long Covid?
15	[GO]	The Medical Letter on Drugs and Therapeutics	2023―May―11	COVID-19 Update: An EUA for Vilobelimab (Gohibic) for COVID-19
16	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Mar―30	COVID-19 Update: Pfizer Bivalent Vaccine Booster Dose for Children 6 Months to 4 Years Old
17	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Mar―16	Antiviral Drugs for COVID-19 in Vaccinated Outpatients
18	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Feb―14	COVID-19 Update: Evusheld Unlikely to Neutralize XBB.1.5 Omicron Variant
19	[GO]	The Medical Letter on Drugs and Therapeutics	2023―Jan―17	COVID-19 Update: Tocilizumab (Actemra) FDA-Approved for Treatment of COVID-19 (online only)